Clinical Study on the Safety and Efficacy of QY-1-T in the Treatment of HBV-associated Advanced Liver Cancer
Clinical Study on the Safety and Efficacy of QY-1-T in the Treatment of HBV-associated Advanced Liver Cancer is a NA clinical asset sponsored by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine in Liver Cancer. SEO and diligence focus: QY-1-T, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Indication: Liver Cancer
Modality: small molecule
Target: QY-1-T
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 25, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: QY-1-T
View original source fields
Condition raw: Liver Cancer
Condition normalized: Liver Cancer
Modality raw: small molecule
Modality normalized: small molecule
Target raw: QY-1-T
Target normalized: QY-1-T